126 related articles for article (PubMed ID: 3464659)
21. Immunohistochemical characterization of ovarian borderline tumors of intestinal and mullerian types.
Rutgers JL; Bell DA
Mod Pathol; 1992 Jul; 5(4):367-71. PubMed ID: 1495942
[TBL] [Abstract][Full Text] [Related]
22. [An early detection of the recurrence of serous cystadenocarcinoma of the ovary with the tumor marker CA125 levels].
Usui N; Suzuki M; Takada M
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Jun; 44(6):703-9. PubMed ID: 1506732
[TBL] [Abstract][Full Text] [Related]
23. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer.
Koelbl H; Schieder K; Neunteufel W; Bieglmayer C
Neoplasma; 1989; 36(4):473-8. PubMed ID: 2770933
[TBL] [Abstract][Full Text] [Related]
24. Carcinoembryonic antigen in human ovarian neoplasms.
Marchand A; Fenoglio CM; Pascal R; Richart RM; Bennett S
Cancer Res; 1975 Dec; 35(12):3807-10. PubMed ID: 1192434
[TBL] [Abstract][Full Text] [Related]
25. S-100 protein in ovarian tumors. A comparative immunohistochemical study of 135 cases.
Lin M; Hanai J; Wada A; Ozaki M; Nasu K; Okamoto S; Matsumoto K
Acta Pathol Jpn; 1991 Mar; 41(3):233-9. PubMed ID: 2068948
[TBL] [Abstract][Full Text] [Related]
26. [Serum sialyl Tn antigen as a prognostic marker in patients with epithelial ovarian cancer].
Kobayashi H; Terao T; Kawashima Y
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Jan; 44(1):14-20. PubMed ID: 1541859
[TBL] [Abstract][Full Text] [Related]
27. [Establishment and characterization of a human ovarian adenocarcinoma cell line OC-8611].
Huang JS
Zhonghua Zhong Liu Za Zhi; 1989 Nov; 11(6):416-8. PubMed ID: 2634538
[TBL] [Abstract][Full Text] [Related]
28. A study of cyst fluid and plasma carcinoembryonic antigen in patients with cystic ovarian neoplasms.
van Nagell JR; Pletsch QA; Goldenberg DM
Cancer Res; 1975 Jun; 35(6):1433-7. PubMed ID: 805659
[TBL] [Abstract][Full Text] [Related]
29. [Studies on tissue-localization of various tumormarkers in ovarian tumors by immunoperoxidase method].
Tanimura T
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Nov; 37(11):2344-52. PubMed ID: 2416855
[TBL] [Abstract][Full Text] [Related]
30. Tumor markers of epithelial ovarian neoplasms.
Khalifa MA; Sesterhenn IA
Int J Gynecol Pathol; 1990; 9(3):217-30. PubMed ID: 2197239
[TBL] [Abstract][Full Text] [Related]
31. [Immunohistochemical studies of ras oncogene product p21 in human ovarian tumors].
Yaginuma Y; Yamashita K
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1409-16. PubMed ID: 2685141
[TBL] [Abstract][Full Text] [Related]
32. Measurement of CA125, carcinoembryonic antigen, and alpha-fetoprotein in ovarian cyst fluid: diagnostic adjunct to cytology.
Pinto MM; Bernstein LH; Brogan DA; Parikh F; Lavy G
Diagn Cytopathol; 1990; 6(3):160-3. PubMed ID: 1696873
[TBL] [Abstract][Full Text] [Related]
33. [Study of the mechanism of tumor marker CA125 in serum].
Kiyozuka Y; Noda T; Adachi S; Adachi S; Akada S; Ichijo M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Dec; 41(12):1951-8. PubMed ID: 2592818
[TBL] [Abstract][Full Text] [Related]
34. An immunohistochemical study of distribution of carcinoembryonic antigen in epithelial tumours of the ovary.
Heald J; Buckley CH; Fox H
J Clin Pathol; 1979 Sep; 32(9):918-26. PubMed ID: 229130
[TBL] [Abstract][Full Text] [Related]
35. Ovarian mucinous cystadenocarcinoma producing alpha-fetoprotein.
Konishi I; Fujii S; Kataoka N; Noda Y; Okamura H; Yamabe H; Mori T
Int J Gynecol Pathol; 1988; 7(2):182-9. PubMed ID: 2456275
[TBL] [Abstract][Full Text] [Related]
36. Improved specificity of the CA 125 enzyme immunoassay for ovarian carcinomas by use of the ratio of CA 125 to carcinoembryonic antigen.
Wu JT; Miya T; Knight JA; Knight DP
Clin Chem; 1988 Sep; 34(9):1853-7. PubMed ID: 2458203
[TBL] [Abstract][Full Text] [Related]
37. Antigen CA125 in tumor tissue and serum from patients with adenocarcinoma of the ovary.
Maughan TS; Fish RG; Shelley M; Jasani B; Williams GT; Adams M
Gynecol Oncol; 1988 Jul; 30(3):342-6. PubMed ID: 2839394
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical and immunoelectron microscopic study of an amylase-producing, CA19-9 positive ovarian mucinous cystadenocarcinoma.
Teshima H; Kitamura H; Mizoguchi Y; Hino S; Mizutani K; Mori H; Kigawa T
Gynecol Oncol; 1988 Jul; 30(3):372-80. PubMed ID: 2455679
[TBL] [Abstract][Full Text] [Related]
39. Expression of CEA, CA125, CA19-9 and human milk fat globule membrane antigen in ovarian tumours.
Macdonald F; Bird R; Stokes H; Russell B; Crocker J
J Clin Pathol; 1988 Mar; 41(3):260-4. PubMed ID: 3162916
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical differentiation between ovarian granulosa cell tumors and ovarian carcinomas.
Gitsch G; Kohlberger P; Hanzal E; Kölbl H; Breitenecker G
Arch Gynecol Obstet; 1991; 249(4):173-7. PubMed ID: 1665684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
